Fidelity Investments’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.1M | Sell |
2,470,057
-10,363
| -0.4% | -$105K | ﹤0.01% | 1622 |
|
|
2025
Q1 | $13.8M | Buy |
2,480,420
+12,611
| +0.5% | +$70.4K | ﹤0.01% | 1800 |
|
|
2024
Q4 | $19.9M | Sell |
2,467,809
-1,911,010
| -44% | -$15.4M | ﹤0.01% | 1728 |
|
|
2024
Q3 | $44.9M | Sell |
4,378,819
-541,541
| -11% | -$5.55M | ﹤0.01% | 1424 |
|
|
2024
Q2 | $34.8M | Sell |
4,920,360
-104,240
| -2% | -$737K | ﹤0.01% | 1451 |
|
|
2024
Q1 | $69.1M | Sell |
5,024,600
-1,977,508
| -28% | -$27.2M | ﹤0.01% | 1197 |
|
|
2023
Q4 | $64.4M | Buy |
7,002,108
+3,869,914
| +124% | +$35.6M | ﹤0.01% | 1191 |
|
|
2023
Q3 | $18.9M | Sell |
3,132,194
-600,054
| -16% | -$3.63M | ﹤0.01% | 1603 |
|
|
2023
Q2 | $29M | Sell |
3,732,248
-274,851
| -7% | -$2.13M | ﹤0.01% | 1483 |
|
|
2023
Q1 | $22.8M | Sell |
4,007,099
-9,509
| -0.2% | -$54.2K | ﹤0.01% | 1558 |
|
|
2022
Q4 | $23.7M | Sell |
4,016,608
-331,784
| -8% | -$1.95M | ﹤0.01% | 1552 |
|
|
2022
Q3 | $13.9M | Sell |
4,348,392
-6,790
| -0.2% | -$21.7K | ﹤0.01% | 1758 |
|
|
2022
Q2 | $19.5M | Sell |
4,355,182
-63,231
| -1% | -$283K | ﹤0.01% | 1654 |
|
|
2022
Q1 | $23.6M | Sell |
4,418,413
-1,488,866
| -25% | -$7.95M | ﹤0.01% | 1711 |
|
|
2021
Q4 | $86.8M | Buy |
5,907,279
+9,627
| +0.2% | +$142K | 0.01% | 1173 |
|
|
2021
Q3 | $123M | Buy |
5,897,652
+393,280
| +7% | +$8.22M | 0.01% | 1011 |
|
|
2021
Q2 | $97.4M | Buy |
5,504,372
+120
| +0% | +$2.12K | 0.01% | 1126 |
|
|
2021
Q1 | $135M | Buy |
5,504,252
+51,905
| +1% | +$1.27M | 0.01% | 954 |
|
|
2020
Q4 | $185M | Buy |
5,452,347
+959,019
| +21% | +$32.5M | 0.02% | 778 |
|
|
2020
Q3 | $111M | Buy |
4,493,328
+286,380
| +7% | +$7.09M | 0.01% | 864 |
|
|
2020
Q2 | $139M | Buy |
+4,206,948
| New | +$139M | 0.02% | 741 |
|